SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative: The molecular lesions responsible for the onset and progression of aCML were unknown until 2013, when, by applying NGS techniques, the presence of recurrent somatic mutations in SETBP1 was described (22, 24, 59, 65–70).